ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

Fogarty Leads Grant Program On World Tobacco Research.

July 6, 2001

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

ORI Instructs NSAB to Prepare for Investigation

April 19, 1996

In Brief: Mammography Quality assurance Act Introduced Laurence Marton Succeeds Brown At Wisconsin

November 1, 1991

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982